Please login to the form below

Not currently logged in

Merck bulks up in cancer with $2.2bn Peloton buy

Merck and Co - US headquarters

Another significant bolt-on in oncology

Verily unveils next-gen trials alliance with Novartis, Pfizer

VerilyNew data methods and tech will be used to streamline trials

Huntsworth bolsters market access capabilities with Creativ-Ceutical

HuntsworthAdds new capabilities and global presence

Boehringer eyes rare disease use for respiratory blockbuster

Would help support respiratory franchise

No deal or revoke looming as fourth vote on Brexit nears

Brexit Parliament ProtestVoters set to protest via EU elections, no-deal remains possibility

Research charity LifeArc cashes $1.2bn royalty from Keytruda

LifeArcUK medical research charity pledges to expand its work

Keytruda monotherapy fails in triple negative breast cancer

merck-keytruda-pembrolizumab-melanomaFails in gambit to outflank rival Tecentriq

RNA-focused biotech Storm Therapeutics raises extra £14m

Storm TherapeuticsNew head of translational oncology also hired

Europe responding to gene therapy challenge, but picture remains fragmented

EU flag bodyGermany, Italy and England using outcomes-based deals

Q&A with Tim Cockroft

PME interviews the founding director of akt health communications

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
Turning learning into action: The challenge of behaviour change